[ Tips ] 一分鐘使用導覽
商品編號： 9-210-040 出版日期： 2010/02/26 作者姓名： Baldwin, Carliss Y.;Becker, Bo;Dessain, Vincent 商品類別： Finance 商品規格： 32p 再版日期： 2011/09/28 地域： Switzerland 產業： Biotechnology;Pharmaceuticals 個案年度： 2008 - 2009
商品敘述：
Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche''s biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche''s strategy with respect to Genentech, the pros and cons of merging the two companies with different cultures, the value of Genentech, and the tactics of a hostile tender offer.
涵蓋領域：
Corporate governance;Corporate strategy;Mergers & acquisitions;Tender offers
相關資料：
Case Teaching Note, (5-211-039), 22p, by Bo Becker, Carliss Y. Baldwin;Spreadsheet Supplement, (9-211-706), 0p, by Bo Becker;Industry and Background Note, (9-803-200), 10p, by Carliss Y. Baldwin, Constance E. Bagley, James Quinn
哪些人也有訂購？